Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for patients with lumbar vertebral fracture without surgical indication
IRCT20101122005230N3Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of alendronate in lumbar fracture (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Low back pain at 6 months. Started Jun 2019; status: completed.
02
Drugs
alendronate
03
Conditions
lumbar fracture
Beyond the preview
Go deeper on IRCT20101122005230N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101122005230N3.